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Abstract
Background: The liver microenvironment plays a key role in liver fibrosis and carcinogenesis. This study aimed to fill
the gap in knowledge on the interaction between hepatic stellate cells and endothelial progenitor cells with biomarkers
of liver fibrosis and/or carcinogenesis, including Col1A1, TGF-β, and tenascin-C. Methods: CD34+ stem cells were
isolated from umbilical-cord-blood mononuclear cells. 2D and 3D co-culture of CD34+ UCB SCs and LX2 was
performed. The cells were incubated in a CO2 incubator for three days. Morphological observation, qRT-PCR of TGFβ1 and COL1A1, and immunocytochemistry of tenascin-C were performed. Results: CD34+ UCB SCs were viable in
the 2D and 3D co-culture for 24 h. 3D co-culture of CD34+ UCB SCs and LX2 inhibited in vitro liver fibrosis by
lowering Col 1A1 expression as compared to control. We observed lower TGF-β expression in 3D co-culture on days 1
and 2 followed by higher expression of TGF-β on day 3. 2D co-culture of CD34+ UCB SCs and LX2 showed a different
level of COL1A1 and TGF- β expression compared with 3D co-culture. Spheroids from 2D co-culture of CD34+ UCB
SCs and LX-2 showed immunoreactivity against tenascin-C. Conclusion: Interaction between LX-2 and CD34+ UCB
SCs in 3D co-culture inhibits in vitro liver fibrosis. The viability of CD34 + UCB SCs is essential for attenuation of
TGF-β signaling in LX-2.
Keywords: CD34+, collagen 1A1, spheroid formation, tenascin-C, TGF-β signaling, umbilical cord blood

tissue changes. Liver fibrosis, cirrhosis, and
carcinogenesis occur as a spectrum of reversible to
irreversible changes in liver histology. In vitro 3D coculture of liver cells with or without non-liver cells offer
a 3D liver microenvironment with cell-to-cell spatial
contact and cell-to-matrix interactions, thus mimicking
tissue responses. This method is useful for the study of
liver fibrogenesis and carcinogenesis in the absence of
culture plate attachment inherent in 2D co-culture. 2D
co-culture potentially leads to biases from attached cells
as they produce cell-adhesion molecules to the culture
plate or each other. Cell-to-cell spatial contact and cellto-matrix interaction in 2D co-culture is different from
in vivo tissue response.4–6

Introduction
Hepatocellular carcinoma (HCC) causes 810,000 cancer
mortalities each year.1 The increasing number of
hepatitis B virus (HBV) infection cases has led to a
higher incidence of liver cancer in the developing
world. It is estimated that 248 million people worldwide
are infected with HBV.2 According to Globocan 2018
data, the incidence rate of HCC in Indonesia was 5.8–
8.4 per 100,000 people.1 The risk of developing liver
cancer in patients with HBV-induced cirrhosis is eightfold higher than in HBV carriers without cirrhosis.3
At the heart of progression from HBV-induced cirrhosis
to liver cancer is the liver microenvironment. The
microenvironment of the liver comprises liver
parenchymal cells (hepatocytes); non-parenchymal cells
of the liver, e.g. kupfer cells, hepatic stellate cells,
endothelial cells, and cholangiocytes; and the extracellular
matrix (ECM). Interaction between cell-to-cell and cellto-matrix in the liver microenvironment determines

Hepatic stellate-cell line LX-2 has been used as an
established in vitro model of liver fibrosis or
carcinogenesis. The characteristics of LX-2 are
activated hepatic stellate cells with a myofibroblast
phenotype, high proliferation abilities, more abundant
collagen type I secretion to the ECM, and fewer matrix
75
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metalloproteinase
degradation
enzymes.
These
characteristics support the progression of liver fibrosis
into liver cirrhosis.7,8 The main cytokine in the event of
liver fibrosis and carcinogenesis is TGF-β.3 TGF-β
signaling also occurs at the initiation of HCC and the
EMT process (metastasis of HCC). Co-culture of HCC
with hepatic stellate cells produced a higher
proliferation rate of HCC.9 Hepatic stellate cells
differentiate into cancer-associated fibroblasts (CAF)
upon stimulation of the exosome or miRNA-21
secretion by HCCs in the microenvironment. 10 Cysteinrich 61 (CCN1/Cyr61) is an ECM protein that affects
and increases the effect of the LX-2 cell line on Hep2G
(liver cancer cell line) by promoting the viability,
migration, and invasion capacity of Hep2G in vitro. 11
The role of CD34+ hematopoietic SCs in liver cirrhosis
and carcinogenesis is partially understood. CD34+
hematopoietic SCs are derived from the bone marrow
by aspiration or from UCB.12 The potency of CD34+
UCB SCs for liver regenerative therapy has been
reported in in vivo studies. The use of CD34 + UCB SCs
in non-obese, diabetic, and immunodeficient mice with
liver injury demonstrated the fusion of the CD34 + UCB
SCs with the liver tissue, improved liver parameters,
and a reduced mortality rate in the mice. 12 CD34+ stem
cells are also known as endothelial progenitor cells
(EPCs). Patients with liver cirrhosis have an increased
number of circulating EPCs, which correlates with the
degree of liver cirrhosis. EPC can promote angiogenesis
by secretion of VEGF and differentiation into mature
endothelial cells followed by incorporation into injured
vessels.13–15 An in vitro study by Liu et al. demonstrated
the release of placental growth factor (PlGF) from CAF
which originated from activated hepatic stellate cells
that increased angiogenesis in HCC.16
Fragmented concepts on the role of hepatic stellate cells
and EPC from HCC patients, cirrhosis patients, liver
fibrosis, and cancer animal models required further
investigation into the interaction between hepatic
stellate cells and EPCs at an in vitro level. This study
aimed to fill the gap of knowledge on the interaction
between hepatic stellate cells and EPCs with biomarkers
of liver fibrosis and the carcinogenesis microenvironment,
including Col1A1, TGF-β, and tenascin-C.

Methods
This study was an in vitro experimental study using
two cell populations: CD34 + UCB SCs, which were
isolated from the mononuclear fraction of UCB, and
LX-2 cells, which were obtained from Millipore (Cat
No. #SCC064). The experiments were replicated three
times. This study was performed from August 2015 to
September 2016 at the Institute of Human Virology
and Cancer Biology Faculty of Medicine Universitas
Indonesia–Cipto Mangunkusumo Central Hospital
Makara J Health Res.

(FKUI-RSCM), Department of Histology FKUI, the
flow cytometry facility at the FKUI Integrated Lab,
and the Stem Cell Medical Technology Integrated
Service Unit at FKUI-RSCM. The protocol of this
study was approved by the FKUI Ethical Committee
(no 751a/UN2.F1/ETIK/VIII/2015).
Isolation and characterization of CD34+ UCB SCs.
CD34+ UCB SCs were isolated from cryopreserved cord
blood, which was a generous gift from Cellsafe and the
Stem Cell Medical Technology Integrated Service Unit
at RSCM-FKUI. After thawing the cryopreserved cord
blood, the cells underwent erythrocyte lysis and were
further separated by Ficoll-Hypaque gradient-density
centrifugation. CD34+ cell isolation was performed
using a human CD34 microbead kit (Miltenyi Biotec,
Bergisch Gladbach, Germany) according to the
manufacturer’s instructions. The phenotype of UCB
CD34+ SCs was evaluated by flow cytometry analysis
of CD34.
2D co-culture of CD34+ UCB SCs and LX-2 cells.
The co-culture process for CD34+ UCB SCs and LX-2
cells, in particular the maintenance of cell health, is
difficult, so this study was only conducted over a period
of three days. The 2D culture was performed using a 96well plate with a total of 10,000 CD34 + UCB SCs per
well in suspension with 10,000 LX-2 cells per well.
Two wells of the 2D co-culture in the 96-well plate
were prepared. The first well was observed under an
inverted microscope, documented, and harvested after
one day in culture. The second well underwent a similar
protocol after two days in culture. In addition, a 2D
culture was performed using a 24-well plate for the coculture of CD34+ UCB SCs and LX-2 cells for three
days. A total of 25,000 CD34+ UCB SCs per well were
mixed with 25,000 LX-2 cells in suspension. The well
was observed under an inverted microscope,
documented, and harvested on day 3.
3D co-culture of CD34+ UCB SCs and LX-2 cells
with the hanging drop method. This culture method
used a 10 cm petri dish. One milliliter of a suspension
comprised of 50,000 CD34+ and 50,000 LX-2 cells in a
1:1 (v/v) ratio was prepared. Furthermore, 30 µL of the
suspension was carefully pipetted onto the inner side of
a petri dish lid (open position). Each lid ultimately
contained an average of 20–30 drops. The lower petri
dish was filled with 5 mL of DMEM or PBS. In a single
movement, the upper lid was flipped to obtain a closed
petri dish position. The drops were hanging on the inner
surface of the upper lid. The dish was incubated in a
CO2 incubator at 37 °C, 5% CO2, and 95% humidity.
Four dishes were prepared. Three dishes were harvested
on each of day 1, day 2, and day 3. A fourth dish was
used as a negative control and contained the 3D hanging
drop monoculture of HSCs that were harvested on day 3.
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A Quantitative reverse transcriptase PCR (qRTPCR) of collagen 1 subtype A1 (COL1A1) and TGF1. RNA from the harvested cells was isolated using the
TriPure RNA Isolation Reagent (Roche, France). cDNA
synthesis from RNA samples was performed using
AccuPower CycleScript RT PreMix (dN6) (Bioneer,
US). qRT-PCR was used to measure the mRNA
expression levels of COL1A1 and TGF-β1 and was
performed with a LightCycler Nano Master (Roche,
France) and these levels were compared to those of the
housekeeping gene beta-actin. The forward primer used
for COL1A1 was 5'AGGTCCCCCTGGAAAGAA-3',
and the reverse primer for COL1A1 was
5'AATCCTCGAGCACCCTGA-3'; the forward primer
for TGF-β1 was 5'TGAACCGGCCTTTCCTGCTTCTC
ATG-3', and the reverse primer for TGF-β1 was
5'GCGGAAGTCAATGTACAGCTGCCGC-3'.
The
volume of the reagent was 20 μL, which comprised 3
μL PCR grade H2O, 1 μL forward primer (10 µM), 1 µL
reverse primer (10 µM), 10 μL SYBR-Green qRT-PCR
Master Mix, and 5 μL (100 ng) cDNA template. The
reagents were pipetted into LightCycler 8-Tube Strips
(clear) (Roche, France). Then, they underwent
LightCycler Nano Master qPCR with an optimized
cycle protocol. The qRT-PCR result was obtained by
calculation with Livak formulas.
Immunochemistry of tenascin-C. The harvested 2D
and 3D co-cultures and the negative control were
collected on day 3. The cells were fixed in methanol for
1 h. Nonspecific binding reduction with 10% donkey
serum blocking solution was performed for 1 h.
Incubation with anti-tenascin-C primary antibody
sc9871 (Santa Cruz Biotechnology, US) was performed
for 1 h in a moist chamber at room temperature.
Incubation with biotinylated secondary antibody was
performed, followed by streptavidin-conjugated
peroxidase and 3,3'-diaminobenzidine (DAB) substrate
addition. Nuclear counterstaining was performed with
Hematoxylin Harris. The results were observed under an
inverted microscope and documented. Areas of dark
brown signals, which indicate positive tenascin-C
expression, were described.
Statistical analysis. Data of qRT-PCR Col1A1 and
TGF-β were entered into GraphPad Prism 8 software.
Homogeneity or normal distribution of the data was
tested with a Shapiro–Wilk test. The result was
displayed as mean±SD for normal data distribution
otherwise displayed as min, max, and median value.
Further statistical analysis was conducted to test for
differences between 2D and 3D co-culture.

Results
Characterization of CD34+ UCB SCs. The 2D culture
of UCB SCs showed homogenous mononuclear cells
with a round morphology, non-adherence to the well,
Makara J Health Res.

and suspension in the culture medium. Flow cytometry
analysis revealed the mononuclear cell fraction to be the
target population (Figure 1A). The isotype control is
shown in Figure 1B. Flow cytometry analysis of MACS
(magnetic-activated cell sorting) isolated CD34+ UCB
SCs showed that the purity of CD34+ was 80%. This
percentage was acquired from a gated population in Q4
(i.e. the right lower quadrant) (Figure 1C).
Morphology observation of 2D and 3D co-culture
CD34+ UCB SCs and LX-2. Day 1 of 2D co-culture
CD34+ UCB SCs and LX-2 showed the morphology of
the LX-2 monolayer and suspended CD34+ UCB SCs on
top of the single layer (Figure 2A), and 3D co-culture
showed small cells aggregates of LX-2 and single round
CD34+ UCB SCs suspended around the small cell
aggregates (Figure 2E). Day 2 of 2D co-culture showed
retraction in the periphery of the LX-2 monolayer and
hardly any visible CD34+ UCB SCs (Figure 2B), and
3D co-culture showed medium-sized spheroids and the
absence of CD34+ UCB-SC morphology outside the
spheroid (Figure 2F). This result demonstrated that after
two days of in vitro co-culture, CD34+ UCB SCs no
longer present in the co-culture. Day 3 of 2D culture
showed spheroid micromass formation of LX-2 in
comparison with the monolayer of LX-2 monoculture
(Figure 2C vs. Figure 2D), whereas 3D culture showed
smaller spheroids in comparison to LX-2 3D
monoculture (Figure 2G vs Figure 2H).
mRNA expression of COL1A1. qRT-PCR of COL1A1
mRNA expression level from the 2D co-culture of
CD34+ UCB SCs and LX-2 cells, when normalized with
control (monoculture of LX-2), showed a mean±SD
COL1A1 expression level of 0.052±0.014 on day 1,
0.00003 on day 2, and 1.638±0.0003 on day 3 (Figure
3).
qRT-PCR of COL1A1 mRNA expression level from the
3D (hanging drop) co-culture of CD34+ UCB SCs and
LX-2 cells, when normalized with the monoculture of
LX-2 cells (control), showed a mean±SD COL1A1
expression level of 0.0075 on day 1, 0.0949±0.102 on
day 2, and 0.6391±0.5689 on day 3 (Figure 3).
The data of Col1A1 expression is homogenous based on
the Shapiro–Wilk test (p = 0.053, not significant).
Comparative analysis using multiple t-tests between 2D
and 3D co-culture on each day data set showed no
statistically significant difference between each group (p
> 0.05).
TGF-1 mRNA expression. qRT-PCR of the TGF-
mRNA expression level from the 2D co-culture of
CD34+ UCB SCs and LX-2 cells, when normalized with
TGF-β expression of control, showed that min, max,
and median expression level of TGF- on day 1 was
46.0778, 83.142, and 64.049, respectively. On day 2, the
August 2020 | Vol. 24 | No. 2
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min, max, and median expression levels of TGF- were
0.0154, 0.0442, and 0.0298, respectively. On day 3, the
min, max, and median expression levels of TGF-were
0.091, 0.526, and 0.308, respectively (Figure 4).

expression levels of TGF- were 0.0665, 0.093, and
0.08, respectively. On day 3, the min, max, and median
expression levels of TGF- were 0.0348, 1.675, and
0.855, respectively (Figure 4).

qRT-PCR of the TGF- mRNA expression level from
the 3D (hanging drop) co-culture of CD34+ UCB SCs
and LX-2 cells, when normalized with TGF-β
expression of control, showed a min, max, and median
expression level of TGF- on day 1 of 0.01, 0.108, and
0.059, respectively. On day 2, the min, max, and median

Data of TGF-β expression was not distributed normally
based on a Shapiro–Wilk test (p = 0.007, significant
difference between each group data set). Comparative
analysis using a non-parametric Wilcoxon rank test
showed no statistically significant differences between
each group (p > 0.05).

A

B

C
Figure 1. Flow cytometry analysis from UCB SCs (A) Gating population (B) Isotype IgGγ1 (C) Flow cytometry analysis CD34+
MACS isolated UCB SCs
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A

B

C

D

E

F

G

H

Figure 2. Gradual cellular morphology changes occur in 2D co-culture as shown in A–C. Initially, from 2D co-culture day 1, LX-2
cells appear as attached cells in a single layer, while CD34 + UCB SCs appear as small, round cells dispersed in motion or unattached
to the well (A). After the second day in 2D co-culture, the single-layer LX-2 cells started to retract to the center of the well, thus
forming a micromass (B). On day 3, a larger micromass is formed in 2D co-culture (C). This is called spheroid formation. Compared
with 2D monoculture of LX-2 on day 3, spheroid formation is absent. LX-2 cells in 2D culture remain as single-layer cells attached
to the well (D). In 3D co-culture, gradual morphology changes occur as shown in E–G. From 3D co-culture day 1, cell aggregates
started to form and dispersed in the hanging drop (E). After day 2, 3D co-culture showed spheroid formation (F), which increased in
size on day 3 (G). Compared with the 3D hanging drop of LX-2, the formation of larger spheroids was observed on day 3 (H).
Magnification 200x

Figure 3. Normalized level of mRNA collagen 1A1 expression in 2D and 3D co-cultures of LX-2 and CD34+ UCB SCs. The ratio is
normalized to LX-2 cell monoculture. Each bar represents the mean of triplicate replication of experiments. The error bar represents
the standard deviation

Makara J Health Res.

August 2020 | Vol. 24 | No. 2

80

Septiana, et al.

Figure 4. Normalized level of mRNA TGFbeta expression in 2D and 3D co-cultures of LX-2 and CD34+ UCB SCs. The ratio is
normalized to LX-2 cell monoculture. Each bar represents the median of triplicate replication of experiments. The maximum value is
displayed as the upper line

A

B

E

F

C

D

G

Figure 5. Immunocytochemistry of tenascin-C (A) Negative control for tenascin-C, magnification 200x (B–C) Monoculture LX2,
magnification 200x and 400x (D-E) monoculture LX2 in mix medium (DMEM + RPMI), magnification 200x and 400x. (F-G) 2D
co-culture of CD34+ UCB SCs and LX2, magnification 200x and 400x. Black bar indicates 10 µM
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Tenascin-C expression in 2D co-culture and spheroid
formation. Immunocytochemistry of tenascin-C from
the 2D monoculture of LX-2 cells and 2D co-culture of
CD34+ UCB SCs and LX-2 cells showed areas of dark
brown chromogen substrate, which indicated immunoreactivity to tenascin-C (Figure 5). Immunoreactivity to
tenascin-C (tenascin-C expression) is considered positive
when the brown chromogen substrate (DAB) is
deposited in the extracellular space or cell membrane. In
Figure 4C and 4E, some of the cells showed brown
chromogen substrates in the nucleus of the cells. This
observation could have been due to nonspecific binding
of the tenascin-C antibody. In Figure 4F and 4G, the
area of the dark brown substrate was diffuse throughout
the entire spheroid.
Immunocytochemistry of tenascin-C from the 3D coculture of CD34+ UCB SCs and LX-2 cells was not
established. The sample for immunohistochemistry of
tenascin-C was scarce and difficult to handle. Despite
the effort to cytospin, smear, and perform the drop
method and cytoblock during the preparation of
histology specimens, the 3D samples were lost during
the subsequent liquid change or antibody incubations.
This challenge became an obstacle in 3D co-culture
tenascin-C analysis.

Discussion
Potential anti-fibrotic targets have been identified;
however, effective clinical therapies are still lacking. 17
Therefore, it is important to develop novel strategies to
suppress hepatic stellate cell activation for the
treatment of fibrotic hepatic diseases. 18,19 CD34+ UCB
SCs are a rich source for hematopoietic SCs and EPCs
for use in stem-cell therapy. The purity of CD34+ UCB
SCs isolated by magnetic separation in this study was
80%. This result is comparable to recent CD34 +
isolation reports. 20 Several reasons for using CD34 +
UCB SCs are the following: (i) their less invasive
procurement compared to bone marrow biopsy; (ii)
their higher proliferative capacity; (iii) their lower
HLA expression; and (iv) their higher capacity for
differentiation into hepatocytes compared with bone
marrow hematopoietic SCs. 21,22
The direct interaction of UCB SCs to LX-2 cells
occurred on day 1 and was followed by indirect
interaction of the LX-2 and UCB-SC secretome on
days 2 and 3 of co-culture. Data from this study that
supported the indirect interaction of LX-2 and UCB
SCs include the absence of UCB-SC morphology after
day 2 of co-culture and spheroid formation differences
in the co-culture compared with monoculture. The
difference in spheroid formation on day 3 in 2D coculture vs. monolayer in monoculture demonstrated an
indirect effect of CD34 + UCB SCs on LX-2.
Differences in the size of spheroid formation between
Makara J Health Res.

3D coculture vs. large spheroid size in monoculture on
day 3 also showed an indirect effect of CD34 + UCB
SCs. The disappearance of CD34 + UCB-SC
morphology after day 2 in co-culture demonstrated that
the stem cells were no longer viable. The secretome of
CD34+ UCB SCs remained in the vicinity of the LX-2
and altered the phenotype of LX-2 into activated LX-2
(myofibroblasts).
The difference in spheroid formation between 2D and
3D co-culture compared with monoculture control
raises further questions as to the composition of ECM
protein, specifically Col1A1 (collagen type 1A1).
Liver fibrosis is marked by the deposition of Col1A1
from activated LX-2 in the co-culture. This study
showed the highest peak Col1A1 expression on day 2
for 3D co-culture, while 2D co-culture showed the
lowest peak Col1A1 expression, on day 2. Overall, the
Col1A1 expression of 3D co-culture from day 1 to day
3 remained below the control (LX-2 monoculture 3D).
This result correlates with the formation of smaller
spheroids than the control. Lower Col1A1 deposition
from activated LX-2 leads to a lower level of fibrosis.
This means that in 3D co-culture, direct and indirect
interaction of CD34 + UCB SCs and LX-2
demonstrated inhibition of liver fibrosis in vitro. In
contrast, Col1A1 expression in 2D co-culture on day 3
showed the highest expression: higher than the control
(LX-2 monoculture 2D). This result correlates more
with spheroid formation than with the monolayer
morphology of the control. Higher Col1A1 deposition
from activated LX-2 yields a higher fibrosis level. This
means that in 2D co-culture, direct and indirect
interaction of CD34 + UCB SCs and LX-2 showed the
promotion of liver fibrosis in vitro. Inhibition of in
vitro liver fibrosis is shown by a reversal of hepatic
stellate-cell activity from an active to a quiescent state,
which was indicated by a decrease in COL1A1
expression.23–25 Our 3D co-culture result is in line with
the previous study, which demonstrated inhibition of
in vitro liver fibrosis.
Our result of in vitro liver fibrosis inhibition in the 3D
co-culture could be due to the CD34 + UCB-SC
secretome. The content of the secretomes is EVs
(extracellular vesicles), cytokines, and growth factors.
EVs are small membrane vesicles released by almost
all cell types that contribute to cell-mediated biological
effects in the form of RNA (miRNA, non-coding[nc]RNA, long non-coding [lnc]-RNA), lipid, or
proteins.26,27 Inactivation of LX-2 could be caused by
the release of exosome-enriched Twist1 and
miR214/199-5a clusters, thus reducing CCN2
expression.28 Proteomics analysis of UCB secretome
revealed TGF- β as one of the signaling proteins
identified in the secretome. 29
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The TGF-β signaling pathway plays a key role in liver
fibrosis and carcinogenesis.3 This study showed that in
2D co-culture, TGF-β expression on day 1 was higher
by a range of 46 to 83 fold control and decreased by a
range of 101 to 300 fold control on day 2. On day 3,
TGF-β expression increased by a range of two to 30
fold control in 2D co-culture. Our 3D co-culture result
showed a different trend, with lower TGF-β expression
compared with control on day 1 and day 2. However,
on day 3, the maximum TGF- β expression exceeded
the control by 60%. The results of this study
demonstrate that a direct interaction between CD34 +
UCB SCs and LX-2 is essential for the attenuation of
TGF-β signaling, except for the result from 2D coculture day 1. Loss of TGF-β attenuation occurs on
day 3 in both 2D and 3D co-culture results due to the
absence of CD34 + UCB SCs in co-culture after day 2.
This result is in line with the results of previous
studies on the co-culture of SCs and LX-2 cells.30,31
The two studies demonstrated inhibition of LX-2 cell
activity by attenuation of TGF-β signaling. However,
this present study used CD34 + UCB SCs, while the
aforementioned
studies
used
bone
marrow
mesenchymal SCs. An in vivo study by Nakamura et
al. reported that transplantation of CD34 + in rats with
liver cirrhosis decreased TGF-β signaling and
COL1A1 expression.32,33 The potential for ligandreceptor binding between CD34 + UCB SCs and LX-2
to have caused attenuation in TGF-β signaling has not
been identified to date. On day 3, the increase in TGFβ expression is due to the TGF-β from the secretome
of CD34+ UCB SCs.
TGF-β functions as paracrine factor for vasculogenic
mimicry in the HCC microenvironment. Vasculogenic
mimicry is a special vascular structure for highly
aggressive cancer. 34 Tenascin-C is an upregulated
metastasis gene in 3D culture of high metastatic HCC
spheroids.35 Tenascin-C is highly expressed in cancer
stroma (extracellular microenvironment). It plays a
role in modulating the cancer cell microenvironment,
thereby favoring metastasis. 36 Tenascin-C expression
was observed in 2D co-culture of CD34+ UCB SCs and
LX-2 in this present study. Tenascin-C plays an
important role in the activation of hepatic stellate cells
by mediating the interaction between TGF-β and α9β1
integrin. Previous study demonstrated an interaction
that increased collagen type 1 production and hepatic
stellate cell migration. 37
The limitations of this study include challenges in the
establishment of an immunocytochemistry protocol for
tenascin-C and statistically insignificant differences
between 2D and 3D co-culture. The lack of statistical
difference between 2D and 3D co-culture results in
this study restricts interpretation to one based on
trends in the data. Future directions of this study
include liver organoid as an integrated 3D liver
Makara J Health Res.

microenvironment for further investigation of
hepatocytes-to-non-parenchymal liver cells and liver
cells-to-ECM interactions during liver tissue changes,
i.e., liver fibrogenesis and carcinogenesis.

Conclusion
Interaction between LX-2 and CD34+ UCB SCs in 3D
co-culture inhibits in vitro liver fibrosis. Viable CD34 +
UCB SCs are essential for attenuation of TGF-β
signaling in LX-2.
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